Children with Invasive Candidiasis Do Well After Switching IV Antifungal to Enteral
A study on children with invasive candidiasis found that transitioning from intravenous (IV) antifungal treatment to enteral therapy was as effective as completing the full IV course, with 99% of those who transitioned having successful treatment outcomes. The shift to enteral therapy reduced risks associated with IV treatments, such as bloodstream infections from central venous catheters, and offered benefits like easier patient mobility, lower costs, and less environmental impact. The findings, based on data from the Pediatric Antifungal Comparative Effectiveness (PEACE) study, suggest that enteral therapy is a viable option for stable patients, highlighting its potential role in reducing the need for prolonged IV use in pediatric…